Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
Amitava Dasgupta, Melissa Hovanetz, Margaret Olsen, Alice Wells, Jeffrey K Actor
文献索引:Arch. Pathol. Lab. Med. 131(7) , 1094-8, (2007)
全文:HTML全文
摘要
St John's wort induces the activity of the cytochrome P450 enzyme system causing treatment failure because of increased metabolism of many drugs. Procainamide is metabolized by a different pathway to N-acetyl procainamide.To study St John's wort-procainamide interaction using a mouse (Swiss Webster) model.One group of mice (group A, 4 mice in each group) was fed St John's wort each day for 2 weeks (last dose 1 day before administration of procainamide); another group (group B) received the same dose of St John's wort for 1 week. The third group (group C) received only a single dose 1 hour before administration of procainamide, and the control group (group D) received no St John's wort. All groups later received a single oral dose of procainamide. Blood was drawn 1, 4, and 24 hours after administration of procainamide and concentrations in serum of procainamide as well as N-acetyl procainamide were measured using immunoassays.The procainamide concentrations 1 hour after administration was highest in group C (mean, 11.59 microg/mL) followed by group A (9.92 microg/mL), whereas group B (7.44 microg/mL) and control group D (7.36 microg/mL) showed comparable values. The concentration in group C was significantly greater than the control group D (P = .03, 2-tailed independent t test). N-Acetyl procainamide concentrations and estimated half-life of procainamide among groups were comparable. In a separate experiment when mice were fed purified hypericin, the active component of St John's wort, a significant increase in bioavailability (53%) of procainamide was observed compared with the control group.St John's wort has an acute effect to increase bioavailability of procainamide but has no effect on its metabolism.
相关化合物
相关文献:
2007-05-01
[Nat. Chem. Biol. 3(5) , 268-273, (2007)]
2015-01-01
[Drug Metab. Dispos. 43(1) , 126-39, (2014)]
1996-06-01
[J. Pharm. Sci. 85(6) , 595-9, (1996)]
1995-04-01
[J. Pharmacol. Exp. Ther. 273(1) , 315-9, (1995)]
1996-07-01
[J. Clin. Pharmacol. 36(7) , 623-33, (1996)]